-
Balance Medtech’s Interventional Pulmonary Valve Receives Fast-Track Designation from NMPA
•
China’s Beijing Balance Medical Technology Co., Ltd. (SHA: 688198) has announced that it has received fast-track designation from the Center for Medical Device Evaluation, NMPA, for its in-house developed all-comer interventional pulmonary valve and delivery system. This marks the third interventional valve product from Balance Medtech to receive fast-track status…
-
Beijing Balance Medical Secures NMPA Nod for Renatus Transcatheter Aortic Valve System
•
BEIJING—Beijing Balance Medical Technology Co., Ltd (SHA: 688198) has received market approval from the National Medical Products Administration (NMPA) for its Renatus transcatheter aortic valve system. This in-house developed product is now approved for use in patients aged 70 years or older who are diagnosed with symptomatic, calcified, and severe…
-
Beijing Balance Medical Secures NMPA Nod for Pioneering Heart Valve Patch
•
Beijing Balance Medical Technology Co., Ltd (SHA: 688198), a leading medical technology firm based in China, has achieved a significant regulatory milestone with the National Medical Products Administration’s (NMPA) approval for its heart valve biological patch. This marks the first market approval for a product specifically designed for the repair…
-
Beijing Balance Medical Secures NMPA Approval for Innovative Mitral Valve Annuloplasty Ring
•
Beijing Balance Medical Technology Co., Ltd (SHA: 688198), a Chinese medical device company, has received market approval from the National Medical Products Administration (NMPA) for its proprietary mitral valve annuloplasty ring product. This development marks a significant milestone for the company, which aims to provide advanced cardiac solutions to patients.…
-
Beijing Balance Medical Technology’s Transcatheter Aortic Valve System Accepted for NMPA Review
•
China’s Beijing Balance Medical Technology Co., Ltd (SHA: 688198) has announced that the National Medical Products Administration (NMPA) has accepted its market approval filing for a transcatheter aortic valve system for review. Product Features and Clinical ApplicationsThe product is designed for patients with severe aortic valve stenosis who are at…
-
Beijing Balance Medical Receives Approval for Innovative Expandable Artificial Heart Valve in China
•
Beijing Balance Medical Technology Co., Ltd (SHA: 688198), a leading medical technology company in China, has announced the approval of its limited expandable artificial biological heart valve by the Chinese regulatory authorities. This innovative valve is designed to replace diseased, injured, or malformed aortic, mitral, and tricuspid valves, as well…
-
Beijing Balance Medical’s Transcatheter Valve System Enters China’s Innovative Device Review
•
China’s Beijing Balance Medical Technology Co., Ltd (SHA: 688198) has announced that its transcatheter valve system has entered the innovative medical device special review process in China, marking a significant step forward in the advancement of valve replacement therapies. A New Approach to Postoperative Valve ReplacementThe interventional valve system is…
